<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0106233763
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MOXICLAV 1 gm Film Coted Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN,CLAVULANIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        875,125
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        44.6
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MEDOCHEMIE LTD (FACTORY B)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MEDOCHEMIE LTD (FACTORY B)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 601]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            UNITED CORPORATION FOR PHARMACEUTICAL & MEDICAL SERVICES LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CR02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>MOXICLAV is an antibiotic and works by killing bacteria that cause infections. It contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines called &ldquo;penicillins&rdquo; that can sometimes be stopped from working (made inactive). The other active component (clavulanic acid) stops this from happening.</p><p>MOXICLAV is used in adults and children to treat the following infections:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; middle ear and sinus infections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; respiratory tract infections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;urinary tract infections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin and soft tissue infections including dental infections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;bone and joint infections.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take MOXICLAV:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic (hypersensitive) to amoxicillin, clavulanic acid, penicillin or any of the other ingredients of MOXICLAV (listed in section 6)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have ever had a severe allergic (hypersensitive) reaction to any other antibiotic. This can include a skin rash or swelling of the face or neck</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;if you have ever had liver problems or jaundice (yellowing of the skin) when taking an antibiotic.</p><p><strong>Do not take MOXICLAV if any of the above apply to you. </strong>If you are not sure, talk to your doctor or pharmacist before taking MOXICLAV.</p><p>&nbsp;</p><p><strong>Take special care with MOXICLAV </strong></p><p>Talk to your doctor or pharmacist before taking this medicine if you:</p><p>&bull; have glandular fever</p><p>&bull; are being treated for liver or kidney problems</p><p>&bull; are not passing water regularly.</p><p>If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking MOXICLAV.</p><p>In some cases, your doctor may investigate the type of bacteria that is causing your infection. Depending on the results, you may be given a different strength of MOXICLAV or a different medicine.</p><p><strong>Conditions you need to look out for </strong>MOXICLAV can make some existing conditions worse, or cause serious side effects. These include allergic reactions, convulsions (fits) and inflammation of the large intestine. You must look out for certain symptoms while you are taking MOXICLAV, to reduce the risk of any problems. See &lsquo;<em>Conditions you need to look out for&rsquo; </em>in <strong>Section 4</strong>.</p><p><strong>&nbsp;</strong></p><p><strong>Blood and urine tests </strong></p><p>If you are having blood tests (such as red blood cell status tests or liver function tests) or urine tests (for glucose), let the doctor or nurse know that you are taking MOXICLAV. This is because MOXICLAV can affect the results of these types of tests.</p><p>&nbsp;</p><p><strong>Using other medicines </strong></p><p>Please tell your doctor or pharmacist if you are using or have recently used any other medicines. This includes medicines that can be bought without a prescription and herbal medicines.</p><p>If you are taking allopurinol (used for gout) with MOXICLAV, it may be more likely that you&rsquo;ll have an allergic skin reaction.</p><p>If you are taking probenecid (used for gout), your doctor may decide to adjust your dose of MOXICLAV.</p><p>If medicines to help stop blood clots (such as warfarin) are taken with MOXICLAV then extra blood tests may be needed.</p><p>MOXICLAV can affect how methotrexate (a medicine used to treat cancer or rheumatic diseases) works.</p><p>MOXICLAV can affect how Mycophenolate mofetil (a medicine used to prevent the rejection of transpanted organs) works.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant, you think you might be pregnant or if you are breast-feeding, ask your doctor or pharmacist for advice before taking any medicine.</p><p>&nbsp;</p><p><strong>Driving and using machines </strong></p><p>MOXICLAV can have side effects and the symptoms may make you unfit to drive.</p><p>Don&rsquo;t drive or operate machinery unless you are feeling well.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take MOXICLAV exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p><strong>Adults and children weighing 40 kg and over </strong></p><p>&nbsp;</p><p>&bull; Usual dose &ndash; 1 tablet two times a day</p><p>&bull; Higher dose &ndash; 1 tablet three times a day</p><p><strong>&nbsp;</strong></p><p><strong>Children weighing less than 40 kg </strong></p><p>&nbsp;</p><p>Children aged 6 years or less should preferably be treated with MOXICLAV oral suspension or sachets.</p><p>Ask your doctor or pharmacist for advice when giving MOXICLAV tablets to children weighing less than 40 kg.</p><p>&nbsp;</p><p><strong>Patients with kidney and liver problems </strong></p><p>&nbsp;</p><p>&bull; If you have kidney problems the dose might be changed. A different strength or a different medicine may be chosen by your doctor.</p><p>&bull; If you have liver problems you may have more frequent blood tests to check how your liver is working.</p><p>&nbsp;</p><p><strong>How to take MOXICLAV </strong></p><p>&bull; Swallow the tablets whole with a glass of water at the start of a meal or slightly before</p><p>&bull; Space the doses evenly during the day, at least 4 hours apart. Do not take 2 doses in 1 hour.</p><p>&bull; Do not take MOXICLAV for more than 2 weeks. If you still feel unwell you should go back to see the doctor.</p><p>&nbsp;</p><p>I<strong>f you take more MOXICLAV than you should</strong></p><p>If you take too much MOXICLAV, signs might include an upset stomach (feeling sick, being sick or diarrhoea) or convulsions. Talk to your doctor as soon as possible. Take the medicine carton or bottle to show the doctor.</p><p>&nbsp;</p><p><strong>If you forget to take MOXICLAV </strong></p><p>If you forget to take a dose, take it as soon as you remember. You should not take the next dose too soon, but wait about 4 hours before taking the next dose.</p><p>&nbsp;</p><p><strong>If you stop taking MOXICLAV </strong></p><p>Keep taking MOXICLAV until the treatment is finished, even if you feel better. You need every dose to help fight the infection. If some bacteria survive they can cause the infection to come back.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, MOXICLAV can cause side effects, although not everybody gets them. The side effects below may happen with this medicine.</p><p>&nbsp;</p><p><strong>Conditions you need to look out for </strong></p><p><strong>Allergic reactions: </strong></p><ul><li>skin rash</li></ul><p>&nbsp;</p><ul><li>inflammation of blood vessels (<em>vasculitis</em>) which may be visible as red or purple raised spots on the skin, but can affect other parts of the body</li><li>fever, joint pain, swollen glands in the neck, armpit or groin</li></ul><p>&nbsp;</p><ul><li>swelling, sometimes of the face or mouth (<em>angioedema</em>), causing difficulty in breathing</li><li>collapse.</li></ul><p>&nbsp;</p><p><strong>Contact a doctor immediately </strong>if you get any of these symptoms. <strong>Stop taking MOXICLAV. </strong></p><p>&nbsp;</p><p><strong>Inflammation of large intestine </strong></p><p>Inflammation of the large intestine, causing watery diarrhoea usually with blood and mucus, stomach pain and/or fever.</p><p><strong>Contact your doctor as soon as possible </strong>for advice if you get these symptoms.</p><p>&nbsp;</p><p><strong>Very common side effects </strong></p><p>These may affect more than 1 in 10 people</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea (in adults).</p><p>&nbsp;</p><p><strong>Common side effects </strong></p><p>These may affect up to 1 in 10 people</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thrush (<em>candida </em>- a yeast infection of the vagina, mouth or skin folds)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick (nausea), especially when taking high doses</p><p>If affected take MOXICLAV before food.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea (in children).</p><p>&nbsp;</p><p><strong>Uncommon side effects</strong></p><p>These may affect up to 1 in 100 people</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, itching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; raised itchy rash (<em>hives</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; indigestion</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache.</p><p>&nbsp;</p><p>Uncommon side effects that may show up in your blood tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in some substances(<em>enzymes</em>)produced by the liver.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Rare side effects </strong></p><p>These may affect up to 1 in 1000 people</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a</p><p>paler area, with a dark ring around the edge &ndash; <em>erythema multiforme)</em></p><p>If you notice any of these symptoms contact a doctor urgently.</p><p>&nbsp;</p><p>Rare side effects that may show up in your blood tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low number of cells involved in blood clotting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low number of white blood cells</p><p>&nbsp;</p><p><strong>Other side effects</strong></p><p>Other side effects have occured in a very small number of people but their exact frequency is unknown.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions&nbsp; (see above)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the large intestine (see above)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serious skin reactions:</p><p>-a widespread rash with blisters and peeling skin, particularly around the mouth, nose eyes and genitals<em>(Stevens-Johnson syndrome)</em>, and a more severe form, causing extensive peeling of the skin (more than 30% of the body surface &ndash; <em>toxic epidermal necrolysis</em>)</p><p>-widespread red skin rash with small pus-containing blisters (<em>bullous exfoliative </em>&nbsp;<em>dermatitis</em>)</p><p>-a red, scaly rash with bumps under the skin and blisters(<em>exanthemous pustulosis)</em></p><p><strong>Contact a doctor immediately if you get &nbsp;any of these symptoms. </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the liver (<em>hepatitis) </em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; jaundice, caused by increases in the blood of bilirubin(a substance produced in the liver)which may make your skin and whites of the eyes appear yellow</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of tubes in the kidney</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood takes longer to clot</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hyperactivity</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; convulsions (in people taking high doses of MOXICLAV or who have kidney problems)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; black tongue which looks hairy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stained teeth (in children), usually removed by brushing.</p><p>&nbsp;</p><p>Side effects that may show up in your blood or urine tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe reduction in the number of white blood cells</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low number of red blood cells (<em>haemolytic anaemia)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; crystals in urine.</p><p><strong>&nbsp;</strong></p><p><strong>If you get side effects</strong></p><p><strong>Tell your doctor or pharmacist </strong>if any of the side effects become<strong> severe or troublesome, </strong>or if you notice any side effects not listed in this leaflet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>&nbsp;</p><p>Store below 30&deg;C.</p><p>Store in the original package.</p><p>Store in a dry place, protected from light.</p><p>&nbsp;</p><p>Do not use after the expiry date stated on the carton and blister. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substances are: amoxicillin as amoxicillin trihydrate and clavulanic acid as potassium clavulanate.</p><p>MOXICLAV 1g tablets contain 875 mg of amoxicillin as amoxicillin trihydrate and 125 mg of clavulanic acid as potassium clavulanate.</p><p>&nbsp;</p><p>The other ingredients are: microcrystalline cellulose 105, sodium starch glycolate , silica colloidal anhydrous , magnesium stearate, polyvinyl alcohol-part.hydrolyzed,&nbsp; macrogol 4000, talc, lecithin ,titanium dioxide (E171).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	MOXICLAV is available as 1g white film-coated tablets. The tablets are supplied in tropicalised blister packs of aluminium-polyvinylchloride-aluminium. MOXICLAV 1g packs contain 8, 10, 14, 16, 20 tablets. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medochemie Ltd, 1-10 Constantinoupoleos Street, 3011, Limassol, Cyprus</p><p>&nbsp;</p><p>For any information about this medicinal product, please contact the local representative of the Marketing Authorization Holder:</p><p>&nbsp;</p><p><strong>United Corporation for Pharmaceuticals &amp; Medical Services Ltd, Riyadh, Saudi Arabia</strong></p><p>Phone: 0114767000 Ext: 2269</p><p>E-mail: salesmanager@unicorp-sa.com</p><p>&nbsp;</p><p>&nbsp;To report any side effect(s):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Saudi Arabia</em></strong></p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t202" style='position:absolute;
 left:0;text-align:left;margin-left:3.4pt;margin-top:1.65pt;width:254.1pt;
 height:128.7pt;z-index:251656704;mso-height-percent:200;mso-height-percent:200;
 mso-width-relative:margin;mso-height-relative:margin'>
 <v:textbox style='mso-next-textbox:#_x0000_s1026;mso-fit-shape-to-text:t'/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone: 8002490000</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Other GCC States:</em></strong></p><p><!--[if gte vml 1]><v:shape
 id="_x0000_s1027" type="#_x0000_t202" style='position:absolute;margin-left:3.4pt;
 margin-top:9.75pt;width:253.95pt;height:23.95pt;z-index:251657728;
 mso-width-relative:margin;mso-height-relative:margin'/><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>Please contact the relevant competent authority.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><p><strong><em>&nbsp;</em></strong></p><p>&nbsp;</p><p><strong><em>&nbsp;</em></strong></p><p><strong><em>&nbsp;</em></strong></p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p>Council of Arab Health Ministers</p><p><strong>&nbsp;</strong></p><p><!--[if gte vml 1]><v:shape
 id="_x0000_s1028" type="#_x0000_t202" style='position:absolute;left:0;
 text-align:left;margin-left:3.55pt;margin-top:1.5pt;width:306.45pt;height:186.1pt;
 z-index:251658752;mso-width-relative:margin;mso-height-relative:margin'>
 <v:textbox style='mso-next-textbox:#_x0000_s1028'/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p><strong>This is a Medicament</strong></p><p>&nbsp;</p><p>Medicament is a product which affects your health and its consumption contrary to instructions is dangerous for you.</p><p> Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the pharmacist who sold the medicament.</p><p> The doctor and the pharmacist are the experts in medicines, their benefits and risks.</p><p> Do not by yourself interrupt the period of treatment prescribed for you.</p><p> Do not repeat the same prescription without consulting your doctor.</p><p> Keep all medicaments out of reach of children.</p><p>&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	This leaflet was last revised in March 2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">موكسيكلاف هو مضاد حيوي يعمل عن طريق قتل البكتيريا التي تسبب العدوى وهو يتكون من نوعين الأدوية هما الأموكسيسيللين والكلافولانيك أسيد. والأموكسيسيللين ينتمي إلى المجموعة الدوائية المسماة بالبنسيلينات التي يمكن أحيانا أن تتوقف عن العمل (تصبح غير فعالة)، ولكن المكون الآخر (الكلافولانيك أسيد) يمنع ذلك من الحدوث.</p><p dir="RTL">ويستخدم موكسيكلاف مع البالغين والأطفال في علاج الأمراض التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إلتهاب الأذن الوسطى والجيوب الأنفية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; عدوى الجهاز التنفسي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; عدوى المسالك البولية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; عدوى الجلد والأنسجة اللينة بما في ذلك إلتهابات الفم والأسنان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; عدوى العظام والمفاصل</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول موكسيكلاف إذا كنت تعاني من أي مما يلي: </strong><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كانت لديك حساسية من الأموكسيسيللين أو الكلافولانيك أسيد أو البنسيللين أو أي من مكونات موكسيكلاف الأخرى (وارد تفصيلها في الفقرة 6)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا حدثت لديك في السابق حساسية شديدة من أي مضاد حيوي آخر. أعراض هذه الحساسية تشمل الطفح الجلدي وتورم الوجه أو العنق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت قد أصبت من قبل بمشاكل في الكبد مثل الصفراء (اصفرار الجلد) عند تناول مضاد حيوي ما.</p><p dir="RTL"><strong>إذا كانت إحدى هذه الحالات تنطبق عليك فلا تأخذ موكسيكلاف.</strong> إذا لم تكن متأكدا تحدث مع الطبيب أو الصيدلي قبل أن تأخذ موكسيكلاف.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>احتياطات يجب اتخاذها عند أخذ موكسيكلاف</strong>:</p><p dir="RTL">تحدث مع طبيبك أو الصيدلي إذا كنت تعاني من أي من الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حمى غددية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تتناول أدوية كعلاج لمشاكل في الكبد أو الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; عدم التبول بطريقة منتظمة</p><p dir="RTL">إذا كانت إحدى هذه الحالات تنطبق عليك فلا تأخذ موكسيكلاف. إذا لم تكن متأكدا تحدث مع الطبيب أو الصيدلي قبل أن تأخذ موكسيكلاف.</p><p dir="RTL">في بعض الحالات يمكن لطبيبك أن يجري فحصا لمعرفة نوع البكتيريا المسببة للعدوى. ويقوم الطبيب بعد معرفة النتيجة بوصف التركيز المناسب من موكسيكلاف أو يصف دواء آخر.</p><p dir="RTL"><strong>حالات يجب تحريها</strong>، موكسيكلاف يمكن أن يجعل بعض الحالات تسوء، أو أن تحدث آثار جانبية خطيرة عند استخدامه في وجودها. وهي تتضمن حالات الحساسية، والتشنجات (النوبات)، وإلتهابات الأمعاء الغليظة. هناك أعراض يجب الانتباه لها أثناء استخدام موكسيكلاف لتقليل مخاطر حدوث أي مشكلات. أنظر قسم <em>&quot;حالات يجب تحريها&quot;</em> في <strong>الفقرة 4</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>فحوصات الدم والبول</strong>:</p><p dir="RTL">إذا كنت بصدد إجراء فحوصات على الدم (مثل فحوصات حالة كريات الدم الحمراء أو فحوصات وظائف الكبد) أو فحص البول (للجلوكوز)، أخبر الطبيب أو الممرضة بأنك تأخذ موكسيكلاف، لأن موكسيكلاف يمكنه أن يؤثر على نتائج تلك الفحوصات.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>استخدام أدوية أخرى </strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول حاليا أو تناولت مؤخرا أي دواء آخر. بما في ذلك الأدوية التي تحتاج في صرفها لوصفة طبية والأدوية التي لا تحتاج لوصفة طبية والمنتجات العشبية.</p><p dir="RTL">إذا كنت تتناول مادة ألوبرينول (توجد في أدوية النقرس) في نفس الوقت مع موكسيكلاف فيمكن أن يكون هناك احتمال لإصابتك بحساسية الجلد</p><p dir="RTL">إذا كنت تتناول مادة بروبينيسيد (توجد في أدوية النقرس) في نفس الوقت مع موكسيكلاف فيمكن أن يقوم الطبيب بتعديل جرعة موكسيكلاف التي ستأخذها</p><p dir="RTL">إذا كنت تتناول مواد تعمل على منع تجلط الدم (مثل الوارفارين) في نفس الوقت مع موكسيكلاف فيمكن أن يكون هناك حاجة لإجراء المزيد من الفحوصات.</p><p dir="RTL">يمكن لموكسيكلاف أن يؤثر على عمل عقار ميثوتريكسات (دواء يستخدم في علاج السرطان والأمراض الروماتيزمية).</p><p dir="RTL">يمكن لموكسيكلاف أن يؤثر على عمل الميكوفينوليت موفيتيل (دواء يستخدم لمنع رفض الأعضاء المزروعة).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والإرضاع </strong></p><p dir="RTL">إذا كنتي حاملا أو تعتقدين أنك ممن الممكن أن تكوني حاملا، أو كنتي ترضعين طفلك رضاعة طبيعية أطلبي من طبيبك أو من الصيدلي النصيحة قبل تناول أي دواء</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>قيادة السيارات وتشغيل الآلات </strong></p><p dir="RTL">يمكن أن يكون لموكسيكلاف آثار جانبية تجعلك في حالة غير مناسبة لقيادة السيارات، فلا تقم بأعمال قيادة السيارات أو تشغيل الآلات إلا إذا كنت تشعر بأنك في حال جيدة</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>.3&nbsp; </strong><strong>كيفية تناول موكسيكلاف </strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">اتبع تعليمات الطبيب بدقة دائما. اتصل بالطبيب أو الصيدلي إذا لم تكن متأكدا</p><p dir="RTL"><strong>البالغين والأطفال فوق وزن 40 كجم: </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجرعة المعتادة: قرص واحد مرتان يوميا</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجرعة العالية: قرص واحد ثلاث مرات يوميا</p><p dir="RTL"><strong>الأطفال أقل من 40 كجم: </strong></p><p dir="RTL">الأطفال أقل من ستة أعوام من العمر يجب أن يعالجوا بموكسيكلاف شراب أو أكياس.</p><p dir="RTL">أطلب المساعدة من طبيبك أو الصيدلي عند إعطاء أقراص موكسيكلاف للأطفال ذوي الأوزان أقل من 40 كجم</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>المرضى اللذين يعانون من مشاكل في الكلى أو في الكبد: </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كانت لديك مشاكل بالكلى قد تعدل الجرعة. يمكن لطبيبك تغيير تركيز الدواء أو اختيار دواء آخر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كانت لديك مشاكل في الكبد يمكن أن تحتاج إلى إجراء فحوصات أكثر للدم للتأكد من عدم تأثر الكبد.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تبلع الأقراص كاملة مع كوب من الماء، في بداية الوجبة أو قبل الوجبة بفترة وجيزة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; اجعل المدة بين الجرعات متساوية خلال اليوم. لا تجعل المدة بين جرعتين أقل من أربع ساعات. لا تأخذ جرعتين في خلال ساعة واحدة بأي حال من الأحوال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; لا تتناول دواء موكسيكلاڤ لأكثر من أسبوعين، إذا كنت ما تزال تشعر بالمرض، فعليك العودة لمراجعة الطبيب.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا أخذت كمية أكثر من اللازم من موكسيكلاف:</strong></p><p dir="RTL">إذا أخذت كمية من موكسيكلاف أكبر من اللازم فيمكن أن تشمل الأعراض اضطراب بالمعدة (شعور بالغثيان أو غثيان أو إسهال) أو تقلصات. تحدث مع الطبيب بأسرع ما يمكن، خذ علبة أو قارورة الدواء معك ليراها الطبيب.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت جرعة </strong></p><p dir="RTL">إذا نسيت جرعتك من موكسيكلاف خذها حالما تتذكر، ولا تأخذ الجرعة التالية إلا بعد أربعة ساعات على الأقل</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن أخذ موكسيكلاف:</strong></p><p>استمر في تناول الدواء حتى ينتهي حتى ولو شعرت بتحسن. فأنت في حاجة إلى كل الجرعات حتى يتم التخلص من</p><p dir="RTL">العدوى. إذا استطاعت بعض البكتيريا النجاة بسبب التوقف عن أخذ الدواء يمكن للعدوى أن تنتشر مرة أخرى. إذا كانت لديك استفسارات أخرى حول طريقة استخدام هذا الواء اسأل طبيبك أو الصيدلي</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل كافة الأدوية الأخرى، يمكن أن يسبب موكسيكلاف آثارا جانبية، برغم أنه ليس كل من يتناول موكسيكلاف يشعر بهذه الآثار الجانبية. يمكن للآثار الجانبية التالية أن تحدث عند تناول موكسيكلاف:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>حالات تحتاج إلى أن تنتبه لها إذا حدثت: </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>أعراض حساسية (إرجية):</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; طفح جلدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إلتهاب الأوردة الدموية (فاسكوليتيس) ويمكن أن يظهر على هيئة بقع حمراء أو أرجوانية منتفخة على الجلد كما يمكن أن تصيب أجزاء أخرى من الجسم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الحمى، ألم المفاصل، تورم الغدد في الرقبة أو في الإبط بين الساقين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تورم في الوجه أو الفم يسبب صعوبة في التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الإنهيار</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إتصل بطبيبك فورا</strong> إذا أحسست بأي من الأعراض المذكورة <strong>وتوقف عن أخذ موكسيكلاف</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إلتهاب الأمعاء الغليظة </strong></p><p dir="RTL">إلتهاب في الأمعاء الغليظة ينتج عنه إسهال مائي يكون عادة مختلطا بدم أو مخاط، ألم في المعدة و/أو ارتفاع في درجة الحرارة</p><p dir="RTL"><strong>إتصل بطبيبك بأسرع ما يمكن</strong> إذا أحسست بأي من هذه الأعراض.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أعراض جانبية شائعة جداً: </strong></p><p dir="RTL">يمكن أن تصيب هذه الأعراض أكثر من واحد من كل عشرة أشخاص:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الإسهال (عند البالغين)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أعراض جانبية شائعة:</strong></p><p dir="RTL">أعراض يمكن أن تصيب واحد من كل عشرة أشخاص:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الإلتهاب الفطري (كانديدا -خمائر تصيب المهبل أو الفم أو الثنيات الجلدية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; شعور بالغثيان، خاصة مع الجرعات العالية</p><p dir="RTL">إذا أصبت خذ موكسيكلاف قبل الأكل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; القيء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الإسهال (عند الأطفال)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>أعراض جانبية غير شائعة:</strong></p><p dir="RTL">يمكن لهذه الأعراض أن تصيب حتى واحد من كل مائة شخص:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; طفح جلدي، حكة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الشرى - طفح جلدي مرتفع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; سوء الهضم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الدوخة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الصداع</p><p dir="RTL">&nbsp;</p><p dir="RTL">أعراض جانبية غير شائعة تظهر في نتائج تحاليل الدم:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; زيادة في بعض المواد (الإنزيمات) التي يفرزها الكبد</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أعراض جانبية نادرة:</strong></p><p dir="RTL">يمكن لهذه الأعراض أن تصيب حتى 1 من كل 1000:</p><p dir="RTL">الطفح الجلدي الذي يمكن أن ينشأ عنه بثور وتبدو كأنها أهداف رماية صغيرة (نقطة داكنة في الوسط تحيط بها منطقة باهتة ثم دائرة داكنة تحيط بالدائرة الباهتة -إيريثيما مالتيفورم).</p><p dir="RTL">إذا أصبت بهذه الأعراض إتصل بطبيب على الفور</p><p dir="RTL">&nbsp;</p><p dir="RTL">أعراض جانبية نادرة تظهر في نتائج تحاليل الدم:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; قلة عدد الخلايا في تجلط الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; قلة عدد خلايا الدم البيضاء</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية أخرى:</strong></p><p dir="RTL">ظهرت بعض الآثار الجانبية على عدد قليل جدا من الأشخاص ولكن غير معروف عددهم بالضبط:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حساسية (تفاعلات إرجية) (أنظر أعلاه)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إلتهاب الأمعاء الغليظة (أنظر أعلاه)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تفاعلات خطيرة بالجلد:</p><p dir="RTL">- &nbsp; طفح جلدي منتشر مع بثور وتقشر البشرة خاصة حول الفم والأنف والعينين والأعضاء التناسلية (متلازمة ستيفينس - جونسون) ، وشكل أكثر شدة ، يسبب تقشر واسع للبشرة (أكثر من 30 % من مساحة سطح الجسم - توكسيك إيبيديرمال نيكرولايسيس)</p><p dir="RTL">-&nbsp;&nbsp; طفح جلدي أحمر منتشر مع بثور تحتوي على صديد (بولوس إكسفولياتيف ديرماتايتس)</p><p dir="RTL">-&nbsp;&nbsp; طفح أحمر صدفي مع نتوءات تحت الجلد وبثور<br />( إيكزانثيموس بوستولوسيس )</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إتصل بطبيبك فورا إذا أصبت بأي من هذه الأعراض. </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إلتهاب الكبد (هيباتايتس)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الصفرة، تحدث بسبب زيادة نسبة البيليروبين في الدم (مادة تتكون في الكبد) مما قد يجعل بشرتك وبياض عينيك يبدو أصفر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إلتهاب القنوات في الكلية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الدم يستغرق وقتا أطول حتى يتجلط</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فرط النشاط</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إنقباضات (عند المرضى الذين يتناولون جرعات عالية من موكسيكلاف، أو الذين لديهم مشاكل بالكلية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; لون أسود باللسان حتى يبدو وكأنه به شعر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تبقع الأسنان (لدى الأطفال) بالعادة يمكن إزالته باستخدام فرشاة الأسنان</p><p dir="RTL">أعراض جانبية قد تظهر في نتائج التحاليل المخبرية للدم والبول:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; انخفاض حاد في عدد خلايا الدم البيضاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; انخفاض في عدد كرات الدم الحمراء. (هيموليتيك أنيميا)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; وجود بلورات في البول</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا أصبت بأي من الأعراض الجانبية: </strong></p><p dir="RTL"><strong>أخبر الطبيب أو الصيدلي</strong> إذا <strong>زادت شدة تلك الأعراض أو أصبحت تسبب لك مشاكل</strong>، أو إذا لاحظت وجود أي عوارض جانبية ليست واردة في هذه النشرة.</p><p dir="RTL">&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; يحفظ موكسيكلاف في مكان آمن بحيث لا يستطيع الأطفال رؤيته أو الوصول إليه</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30 درجة مئوية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تحفظ الأقراص في علبتها الأصلية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تحفظ في مكان جاف بعيدا عن الضوء</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم الدواء بعد تاريخ انتهاء الصلاحية المدون على العلبة وعلى الشريط، وتاريخ انتهاء المفعول هو اليوم الأخير من الشهر المدون.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب عدم التخلص من الأدوية في المجاري والقمامة. إسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها، فهذه الإجراءات تساعد في المحافظة على البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي: أموكسيسيللين على هيئة أموكسيسيللين ترايهيدريت، كلافولانيك أسيد على هيئة بوتاسيوم كلفيولانيت. ويحتوي كل قرص 1 جم من موكسيكلاف على 875 مجم أموكسيسيللين في صورة أموكسيسيللين ترايهيدريت و<br />125 مجم كالفولانيك أسيد في صورة بوتاسيوم كالفولانيت.</p><p dir="RTL">&nbsp;</p><p dir="RTL">المكونات الأخرى هي: سيليلوز دقيق التبلور 105، غليكولات نشاء الصوديوم، السيليكا الغروية اللامائية، ستيرات المغنيزيوم، بولي فينيل الكحول المتحلل جزئيا، ماكروجول 4000، تالك، ليسيثين، ثاني أكسيد التيتانيوم (E171).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">موكسيكلاف متوفر على هيئة أقراص بيضاء مغلفة بتركيز<br />1 جم، في شريط من الألمنيوم -بوليفينيل كلورايد -ألومنيوم يناسب المناطق الحارة والرطبة. ومتوفر في عبوات 8، 10، 14، 16، 20 قرص.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة ميدوكيمي المحدودة،</p><p dir="RTL">1-10<em> </em>شارع قسطنطينوبوليوس، 3011 ليماسول، قبرص</p><p dir="RTL"><strong>للإبلاغ عن أي آثار جانبية: </strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; المملكة العربية السعودية:</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:193px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p><p dir="RTL">المركز الوطني للتيقظ والسلامة الدوائية</p><p dir="RTL">فاكس: 00966112057662</p><p dir="RTL">هاتف: 00966112038222 تحويلات: 2317، 2356، 2353، 2354، 2334، 2340</p><p dir="RTL">هاتف مجاني: 8002490000</p><p dir="RTL">العنوان الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الإلكتروني: www.sfda.govt.sa/npc</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; بقية دول مجلس التعاون الخليجي:</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:195px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">الرجاء الاتصال بالمسئول المختص في البلد الذي تقيم فيه.</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">مجلس وزراء الصحة العرب</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:193px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">إن هذا دواء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; الدواء مستحضر يؤثر على صحتك واستهلاكه خلافاً للتعليمات يعرضك للخطر.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; إتبع بدقة وصفة الطبيب وطريقة الاستعمال المنصوص عليها وتعليمات الصيدلي الذي صرفها لك.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; الطبيب والصيدلي هما الخبيران بالدواء وبنفعه وضره.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; لا تكرر صرف الدواء بدون وصفة طبية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; لا تترك الدواء في متناول الأطفال.</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">مجلس وزراء الصحة العرب</p><p dir="RTL">اتحاد الصيادلة العرب &nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            آخر مراجعة تمت لهذه النشرة كانت آذار/ مارس2022 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Moxiclav 1g film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet of Moxiclav 1g contains amoxicillin trihydrate equivalent to 875 mg amoxicillin base and potassium clavulanate equivalent to 125mg clavulanic acid.
For the full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet.
White, convex, cap-shaped, film coated tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Moxiclav is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute bacterial sinusitis (adequately diagnosed).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute otitis media.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute exacerbations of chronic bronchitis (adequately diagnosed).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Community acquired pneumonia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cystitis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pyelonephritis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bone and joint infections, in particular osteomyelitis.</p><p>&nbsp;</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component.</p><p>&nbsp;</p><p>The dose of Moxiclav that is selected to treat an individual infection should take into account:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The severity and the site of the infection.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The age, weight and renal function of the patient as shown below.</p><p>&nbsp;</p><p>The use of alternative presentations of Moxiclav (e.g. those that provide higher doses of amoxicillin and/or different ratios of amoxicillin to clavulanic acid) should be considered as necessary (see sections 4.4 and 5.1).</p><p>&nbsp;</p><p>For adults and children &ge;40 kg, this formulation of Moxiclav provides a total daily dose of 1750 mg amoxicillin/250 mg clavulanic acid with twice daily dosing and 2625 mg amoxicillin/375 mg clavulanic acid with three times daily dosing, when administered as recommended below. For children &lt;40 kg, this formulation of Moxiclav provides a maximum daily dose of 1000-2800 mg amoxicillin/143-400 mg clavulanic acid, when administered as recommended below. If it is considered that a higher daily dose of amoxicillin is required, it is recommended that another preparation of Moxiclav is selected in order to avoid administration of unnecessarily high daily doses of clavulanic acid (see sections 4.4 and 5.1).</p><p>&nbsp;</p><p>The duration of therapy should be determined by the response of the patient. Some infections (e.g. osteomyelitis) require longer periods of treatment. Treatment should not be extended beyond 14 days without review (see section 4.4 regarding prolonged therapy).</p><p>&nbsp;</p><p><em>Adults and children &ge;40 kg</em></p><p>Recommended doses:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Standard dose: (for all indications) 875 mg/125 mg two times a day.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Higher dose - (particularly for infections such as otitis media, sinusitis, lower respiratory tract infections and urinary tract infections): 875 mg/125 mg three times a day.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p><em>Children &lt;40 kg</em></p><p>Children may be treated with Moxiclav tablets or suspensions.</p><p>Recommended doses:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25 mg/3.6 mg/kg/day to 45 mg/6.4 mg/kg/day given as two divided doses.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Up to 70 mg/10 mg/kg/day given as two divided doses may be considered for some infections (such as otitis media, sinusitis and lower respiratory tract infections).</p><p>&nbsp;</p><p>As the tablets cannot be divided, children weighing less than 25 kg must not be treated with Moxiclav tablets.</p><p>&nbsp;</p><p>The table below presents the received dose (mg/kg body weight) in children weighing 25 kg to 40 kg upon administering a single 875/125 mg tablet.</p><table border="1" cellspacing="0" cellpadding="0"><thead><tr><td style="vertical-align:top"><p><strong>Body weight [kg]</strong></p></td><td style="vertical-align:top"><p><strong>40</strong></p></td><td style="vertical-align:top"><p><strong>35</strong></p></td><td style="vertical-align:top"><p><strong>30</strong></p></td><td style="vertical-align:top"><p><strong>25</strong></p></td><td style="vertical-align:top"><p><strong>Single dose recommended [mg/kg body weight] (see above)</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>Amoxicillin [mg/kg body weight] per single dose (1 film-coated tablet)</p></td><td style="vertical-align:top"><p>21.9</p></td><td style="vertical-align:top"><p>25.0</p></td><td style="vertical-align:top"><p>29.2</p></td><td style="vertical-align:top"><p>35.0</p></td><td style="vertical-align:top"><p>12.5-22.5 (up to 35)</p></td></tr><tr><td style="vertical-align:top"><p>Clavulanic acid [mg/kg body weight] per single dose (1 film-coated tablet)</p></td><td style="vertical-align:top"><p>3.1</p></td><td style="vertical-align:top"><p>3.6</p></td><td style="vertical-align:top"><p>4.2</p></td><td style="vertical-align:top"><p>5.0</p></td><td style="vertical-align:top"><p>1.8-3.2 (up to 5)</p></td></tr></tbody></table><p>&nbsp;</p><p>Children weighing less than 25 kg should preferably be treated with Moxiclav suspension.</p><p>No clinical data are available for amoxicillin/clavulanic acid 7:1 formulations regarding doses higher than 45 mg/6.4 mg per kg per day in children under 2 years</p><p>There are no clinical data for amoxicillin/clavulanic acid 7:1 formulations for patients under 2 months of age.</p><p>Dosing recommendations in this population therefore cannot be made.</p><p>&nbsp;</p><p><em>Elderly</em></p><p>No dose adjustment is considered necessary.</p><p>&nbsp;</p><p><em>Renal impairment</em></p><p>No dose adjustment is required in patients with creatinine clearance (CrCl) greater than 30 ml/min.</p><p>In patients with creatinine clearance less than 30 ml/min, the use of Moxiclav presentations with an amoxicillin to clavulanic acid ratio of 7:1 is not recommended, as no recommendations for dose adjustments are available.</p><p>&nbsp;</p><p><em>Hepatic impairment</em></p><p>Dose with caution and monitor hepatic function at regular intervals (see sections 4.3 and 4.4).</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Oral use.</p><p>Administer at the start of a meal to minimise potential gastrointestinal intolerance and optimise absorption of amoxicillin/clavulanic acid.</p><p>Therapy can be started parenterally according to the SmPC of the IV-formulation and continued with an oral preparation.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substances, to any of the penicillins or to any of the excipients listed in section 6.1.
History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid (see section 4.8).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with amoxicillin/clavulanic acid, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other beta-lactam agents (see sections 4.3 and 4.8).</p><p>&nbsp;</p><p>Serious and occasionally fatal hypersensitivity (including anaphylactoid and severe cutaneous adverse reactions) reactions have been reported in patients on penicillin therapy. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and in atopic individuals. If an allergic reaction occurs, amoxicillin/clavulanic acid therapy must be discontinued and appropriate alternative therapy instituted.</p><p>&nbsp;</p><p>In the case that an infection is proven to be due to an amoxicillin-susceptible organisms(s) then consideration should be given to switching from amoxicillin/clavulanic acid to amoxicillin in accordance with official guidance.</p><p>&nbsp;</p><p>This presentation of amoxicillin/clavulanic acid is not suitable for use when there is a high risk that the presumptive pathogens have resistance to beta-lactam agents that is not mediated by beta-lactamases susceptible to inhibition by clavulanic acid. This presentation should not be used to treat penicillin-resistant <em>S. pneumoniae</em>.</p><p>&nbsp;</p><p>Convulsions may occur in patients with impaired renal function or in those receiving high doses (see 4.8).</p><p>&nbsp;</p><p>Amoxicillin/clavulanic acid should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin.</p><p>&nbsp;</p><p>Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions.</p><p>&nbsp;</p><p>Prolonged use may occasionally result in overgrowth of non-susceptible organisms.</p><p>&nbsp;</p><p>The occurrence at the treatment initiation of a feverish generalized erythema associated with pustula may be a symptom of acute generalized exanthemous pustulosis (AGEP) (see section 4.8). This reaction requires amoxicillin/clavulanic acid discontinuation and contra-indicates any subsequent administration of amoxicillin.</p><p>&nbsp;</p><p>Amoxicillin/clavulanic acid should be used with caution in patients with evidence of hepatic impairment (see sections 4.2, 4.3 and 4.8).</p><p>&nbsp;</p><p>Hepatic events have been reported predominantly in males and elderly patients and may be associated with prolonged treatment. These events have been very rarely reported in children. In all populations, signs and symptoms usually occur during or shortly after treatment but in some cases may not become apparent until several weeks after treatment has ceased. These are usually reversible. Hepatic events may be severe and in extremely rare circumstances, deaths have been reported. These have almost always occurred in patients with serious underlying disease or taking concomitant medications known to have the potential for hepatic effects (see section 4.8).</p><p>&nbsp;</p><p>Antibiotic-associated colitis has been reported with nearly all antibacterial agents including amoxicillin and may range in severity from mild to life threatening (see section 4.8). Therefore, it is important to consider this diagnosis in patients who present with diarrhea during or subsequent to the administration of any antibiotics. Should antibiotic-associated colitis occur, amoxicillin/clavulanic acid should immediately be discontinued, a physician be consulted and an appropriate therapy initiated. Antiperistaltic drugs are contra-indicated in this situation.</p><p>&nbsp;</p><p>Periodic assessment of organ system functions, including renal, hepatic and hematopoietic function is advisable during prolonged therapy.</p><p>&nbsp;</p><p>Prolongation of prothrombin time has been reported rarely in patients receiving amoxicillin/clavulanic acid. Appropriate monitoring should be undertaken when anticoagulants are prescribed concomitantly. Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation (see section 4.5 and 4.8).</p><p>&nbsp;</p><p>In patients with renal impairment, the dose should be adjusted according to the degree of impairment (see section 4.2).</p><p>&nbsp;</p><p>In patients with reduced urine output, crystalluria has been observed very rarely, predominantly with parenteral therapy. During the administration of high doses of amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in order to reduce the possibility of amoxicillin crystalluria. In patients with bladder catheters, a regular check of patency should be maintained (see section 4.9).</p><p>&nbsp;</p><p>During treatment with amoxicillin, enzymatic glucose oxidase methods should be used whenever testing for the presence of glucose in urine because false positive results may occur with non-enzymatic methods.</p><p>&nbsp;</p><p>The presence of clavulanic acid in Moxiclav may cause a non-specific binding of IgG and albumin by red cell membranes leading to a false positive Coombs test.</p><p>&nbsp;</p><p>There have been reports of positive test results using the Bio-Rad Laboratories Platelia <em>Aspergillus</em> EIA test in patients receiving amoxicillin/clavulanic acid who were subsequently found to be free of <em>Aspergillus</em> infection. Cross-reactions with non-<em>Aspergillus</em> polysaccharides and polyfuranoses with Bio-Rad Laboratories Platelia <em>Aspergillus</em> EIA test have been reported. Therefore, positive test results in patients receiving amoxicillin/clavulanic acid should be interpreted cautiously and confirmed by other diagnostic methods.</p><p>&nbsp;</p><p>Moxiclav contains propylene glycol which may cause alcohol-like symptoms</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Oral anticoagulants</u></p><p>Oral anticoagulants and penicillin antibiotics have been widely used in practice without reports of interaction. However, in the literature there are cases of increased international normalized ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin. If co-administration is necessary, the prothrombin time or international normalized ratio should be carefully monitored with the addition or withdrawal of amoxicillin. Moreover, adjustments in the dose of oral anticoagulants may be necessary (see section 4.4 and 4.8).</p><p>&nbsp;</p><p><u>Methotrexate</u></p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.</p><p>&nbsp;</p><p><u>Probenecid</u></p><p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use of probenecid may result in increased and prolonged blood levels of amoxicillin but not of clavulanic acid.</p><p>&nbsp;</p><p><u>Mycophenolate mofetil</u></p><p>In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active metabolite mycophenolic acid (MPA) of approximately 50% has been reported following commencement of oral amoxicillin plus clavulanic acid. The change in pre-dose level may not accurately represent changes in overall MPA exposure. Therefore, a change in the dose of mycophenolate mofetil should not normally be necessary in the absence of clinical evidence of graft dysfunction. However, close clinical monitoring should be performed during the combination and shortly after antibiotic treatment.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p><u>Pregnancy</u></p><p>Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/fetal development, parturition or postnatal development (see section 5.3). Limited data on the use of amoxicillin/clavulanic acid during pregnancy in humans do not indicate an increased risk of congenital malformations. In a single study in women with preterm, premature rupture of the fetal membrane it was reported that prophylactic treatment with amoxicillin/clavulanic acid may be associated with an increased risk of necrotizing enterocolitis in neonates. Use should be avoided during pregnancy, unless considered essential by the physician.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>Both substances are excreted into breast milk (nothing is known of the effects of clavulanic acid on the breast-fed infant). Consequently, diarrhea and fungus infection of the mucous membranes are possible in the breast-fed infant, so that breast-feeding might have to be discontinued.</p><p>Amoxicillin/clavulanic acid should only be used during breast-feeding after benefit/risk assessment by the physician in charge.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. However, undesirable effects may occur (e.g. allergic reactions, dizziness, convulsions), which may influence the ability to drive and use machines (see section 4.8).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse drug reactions (ADRs) are diarrhea, nausea and vomiting.</p><p>&nbsp;</p><p>The ADRs derived from clinical studies and post-marketing surveillance with amoxicillin/clavulanic acid, sorted by MedDRA System Organ Class are listed below.</p><p>&nbsp;</p><p>The following terminologies have been used in order to classify the occurrence of undesirable effects.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; very common (&sup3;1/10);</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; common (&sup3;1/100 to &lt;1/10);</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; uncommon (&sup3;1/1,000 to &lt;1/100);</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rare (&sup3;1/10,000 to &lt;1/1,000);</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; very rare (&lt;1/10,000).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Infections and infestations</strong></p></td></tr><tr><td style="vertical-align:top"><p>Mucocutaneous candidosis</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Overgrowth of non-susceptible organisms</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Reversible leucopenia (including neutropenia)</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Reversible agranulocytosis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Haemolytic anaemia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Prolongation of bleeding time and prothrombin time<sup>1</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders<sup>10</sup></strong></p></td></tr><tr><td style="vertical-align:top"><p>Angioneurotic oedema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Anaphylaxis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Serum sickness-like syndrome</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hypersensitivity vasculitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Dizziness</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Reversible hyperactivity</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Convulsions<sup>2</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Aseptic meningitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhea</p></td><td style="vertical-align:top"><p>Very common</p></td></tr><tr><td style="vertical-align:top"><p>Nausea<sup>3</sup></p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Indigestion</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Antibiotic-associated colitis<sup>4</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Black hairy tongue</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rises in AST and/or ALT<sup>5</sup></p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Hepatitis<sup>6</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cholestatic jaundice<sup>6</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders<sup>7</sup></strong></p></td></tr><tr><td style="vertical-align:top"><p>Skin rash</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Urticaria</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Erythema multiforme</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Stevens-Johnson syndrome</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Toxic epidermal necrolysis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Bullous exfoliative-dermatitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Acute generalised exanthemous pustulosis (AGEP)<sup>9</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Drug reaction with eosinophilia and systemic symptoms (DRESS)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Interstitial nephritis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Crystalluria<sup>8</sup></p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><sup>1</sup>See section 4.4</p><p><sup>2</sup>See section 4.4.</p><p><sup>3</sup>Nausea is more often associated with higher oral doses. If gastrointestinal reactions are evident, they may be reduced by taking amoxicillin/clavulanic acid at the start of a meal.</p><p><sup>4</sup>Including pseudomembranous colitis and haemorrhagic colitis (see section 4.4)</p><p><sup>5</sup>A moderate rise in AST and/or ALT has been noted in patients treated with beta-lactam class antibiotics, but the significance of these findings is unknown.</p><p><sup>6</sup>These events have been noted with other penicillins and cephalosporins (see section 4.4).</p><p><sup>7</sup>If any hypersensitivity dermatitis reaction occurs, treatment should be discontinued (see section 4.4).</p><p><sup>8</sup>See section 4.9</p><p><sup>9</sup>See section 4.4</p><p><sup>10</sup>See sections 4.3 and 4.4</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions to Pharmaceutical Services, Ministry of Health, CY-1475, www.moh.gov.cy / phs Fax: + 357 22608649.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Symptoms and signs of overdose</u></p><p>Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident.</p><p>Amoxicillin crystalluria, in some cases leading to renal failure, has been observed (see section 4.4).</p><p>Convulsions may occur in patients with impaired renal function or in those receiving high doses.</p><p>Amoxicillin has been reported to precipitate in bladder catheters, predominantly after intravenous administration of large doses. A regular check of patency should be maintained (see section 4.4).</p><p>&nbsp;</p><p><u>Treatment of intoxication</u></p><p>Gastrointestinal symptoms may be treated symptomatically, with attention to the water/electrolyte balance.</p><p>Amoxicillin/clavulanic acid can be removed from the circulation by hemodialysis.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Combinations of penicillins, incl. beta-lactamase inhibitors; ATC code: J01CR02.</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bacterial peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.</p><p>Amoxicillin is susceptible to degradation by beta-lactamases produced by resistant bacteria and therefore the spectrum of activity of amoxicillin alone does not include organisms which produce these enzymes.</p><p>Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. Clavulanic acid alone does not exert a clinically useful antibacterial effect.</p><p>&nbsp;</p><p><u>Pharmacokinetic/pharmacodynamic relationship</u></p><p>The time above the minimum inhibitory concentration (T&gt;MIC) is considered to be the major determinant of efficacy for amoxicillin.</p><p>&nbsp;</p><p><u>Mechanisms of resistance</u></p><p>The two main mechanisms of resistance to amoxicillin/clavulanic acid are:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inactivation by those bacterial beta-lactamases that are not themselves inhibited by clavulanic acid, including class B, C and D.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Alteration of PBPs, which reduce the affinity of the antibacterial agent for the target.</p><p>Impermeability of bacteria or efflux pump mechanisms may cause or contribute to bacterial resistance, particularly in Gram-negative bacteria.</p><p>&nbsp;</p><p><u>Breakpoints</u></p><p>MIC breakpoints for amoxicillin/clavulanic acid are those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST)</p><table border="1" cellspacing="0" cellpadding="0"><thead><tr><td rowspan="2" style="vertical-align:top"><p><strong>Organism</strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>Susceptibility Breakpoints (&mu;g/ml)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Susceptible</strong></p></td><td style="vertical-align:top"><p><strong>Intermediate</strong></p></td><td style="vertical-align:top"><p><strong>Resistant</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em><sup>1</sup></p></td><td style="vertical-align:top"><p>&le;1</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt;1</p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em><sup>1</sup></p></td><td style="vertical-align:top"><p>&le;1</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt;1</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus</em><sup>2</sup></p></td><td style="vertical-align:top"><p>&le;2</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt;2</p></td></tr><tr><td style="vertical-align:top"><p>Coagulase-negative staphylococci<sup>2</sup></p></td><td style="vertical-align:top"><p>&le;0.25</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&gt;0.25</p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus</em><sup>1</sup></p></td><td style="vertical-align:top"><p>&le;4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt;8</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus A, B, C, G</em><sup>5</sup></p></td><td style="vertical-align:top"><p>&le;0.25</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt;0.25</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em><sup>3</sup></p></td><td style="vertical-align:top"><p>&le;0.5</p></td><td style="vertical-align:top"><p>1-2</p></td><td style="vertical-align:top"><p>&gt;2</p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteriaceae<sup>1,4</sup></p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>-</p></td><td style="vertical-align:top"><p>&gt;8</p></td></tr><tr><td style="vertical-align:top"><p>Gram-negative Anaerobes<sup>1</sup></p></td><td style="vertical-align:top"><p>&le;4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt;8</p></td></tr><tr><td style="vertical-align:top"><p>Gram-positive Anaerobes<sup>1</sup></p></td><td style="vertical-align:top"><p>&le;4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>&gt;8</p></td></tr><tr><td style="vertical-align:top"><p>Non-species related breakpoints<sup>1</sup></p></td><td style="vertical-align:top"><p>&le;2</p></td><td style="vertical-align:top"><p>4-8</p></td><td style="vertical-align:top"><p>&gt;8</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><sup>1</sup>The reported values are for Amoxicillin concentrations. For susceptibility testing purposes, the concentration of Clavulanic acid is fixed at 2 mg/l.</p><p><sup>2</sup>The reported values are Oxacillin concentrations.</p><p><sup>3</sup>Breakpoint values in the table are based on Ampicillin breakpoints.</p><p><sup>4</sup>The resistant breakpoint of R&gt;8 mg/l ensures that all isolates with resistance mechanisms are reported resistant.</p><p><sup>5</sup>Breakpoint values in the table are based on Benzylpenicillin breakpoints.</p></td></tr></tbody></table><p>&nbsp;</p><p>The prevalence of resistance may vary geographically and with time for selected species, and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Commonly susceptible species</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Enterococcus faecalis</em></p><p><em>Gardnerella vaginalis</em></p><p><em>Staphylococcus aureus </em>(methicillin-susceptible)<sup>&pound;</sup></p><p><em>Streptococcus agalactiae</em></p><p><em>Streptococcus pneumoniae</em><sup>1</sup></p><p><em>Streptococcus pyogenes</em> and other beta-hemolytic streptococci</p><p><em>Streptococcus viridans</em> group</p><p>&nbsp;</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Capnocytophaga </em>spp.</p><p><em>Eikenella corrodens</em></p><p><em>Haemophilus influenzae</em><sup>2</sup></p><p><em>Moraxella catarrhalis</em></p><p><em>Pasteurella multocida</em></p><p>&nbsp;</p><p><u>Anaerobic micro-organisms</u></p><p><em>Bacteroides fragilis</em></p><p><em>Fusobacterium nucleatum</em></p><p><em>Prevotella</em> spp.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Species for which acquired resistance may be a problem</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Enterococcus faecium</em><sup>$</sup></p><p>&nbsp;</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Escherichia coli</em></p><p><em>Klebsiella oxytoca</em></p><p><em>Klebsiella pneumoniae</em></p><p><em>Proteus mirabilis</em></p><p><em>Proteus vulgaris</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Inherently resistant organisms</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Acinetobacter</em> sp.</p><p><em>Citrobacter freundii</em></p><p><em>Enterobacter</em> sp.</p><p><em>Legionella pneumophila</em></p><p><em>Morganella morganii</em></p><p><em>Providencia</em> spp.</p><p><em>Pseudomonas</em> sp.</p><p><em>Serratia</em> sp.</p><p><em>Stenotrophomonas maltophilia</em></p><p>&nbsp;</p><p><u>Other micro-organisms</u></p><p><em>Chlamydophila pneumoniae</em></p><p><em>Chlamydophila psittaci</em></p><p><em>Coxiella burnetti</em></p><p><em>Mycoplasma pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p><sup>$</sup>Natural intermediate susceptibility in the absence of acquired mechanism of resistance.</p><p><sup>&pound;</sup>All methicillin-resistant staphylococci are resistant to amoxicillin/clavulanic acid.</p><p><sup>1</sup><em>Streptococcus pneumoniae </em>that are resistant to penicillin should not be treated with this presentation of amoxicillin/clavulanic acid (see sections 4.2 and 4.4).</p><p><sup>2</sup>Strains with decreased susceptibility have been reported in some countries in the EU with a frequency higher than 10%.</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption </u></p><p>Amoxicillin and clavulanic acid, are fully dissociated in aqueous solution at physiological pH. Both components are rapidly and well absorbed by the oral route of administration. Absorption of amoxicillin/clavulanic acid is optimized when taken at the start of a meal. Following oral administration, amoxicillin and clavulanic acid are approximately 70% bioavailable. The plasma profiles of both components are similar and the time to peak plasma concentration (Tmax) in each case is approximately one hour.</p><p>&nbsp;</p><p>The pharmacokinetic results for a study, in which amoxicillin/clavulanic acid (875 mg/125 mg tablets given twice daily) was administered in the fasting state to groups of healthy volunteers are presented below.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="6" style="vertical-align:top"><p>Mean (&plusmn;SD) pharmacokinetic parameters</p></td></tr><tr><td style="vertical-align:top"><p>Active substance(s) administered</p></td><td style="vertical-align:top"><p>Dose</p><p>(mg)</p></td><td style="vertical-align:top"><p>Cmax</p><p>(&mu;g/ml)</p></td><td style="vertical-align:top"><p>Tmax*</p><p>(h)</p></td><td style="vertical-align:top"><p>AUC(0-24h)</p><p>(&mu;g.h/ml)</p></td><td style="vertical-align:top"><p>T1/2</p><p>(h)</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>Amoxicillin</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA 875mg/125mg</p></td><td style="vertical-align:top"><p>875</p></td><td style="vertical-align:top"><p>11.64&plusmn;2.78</p></td><td style="vertical-align:top"><p>1.5 (1.0-2.5)</p></td><td style="vertical-align:top"><p>53.52&plusmn;12.31</p></td><td style="vertical-align:top"><p>1.19&plusmn;0.21</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>Clavulanic acid</p></td></tr><tr><td style="vertical-align:top"><p>AMX/CA 875mg/125mg</p></td><td style="vertical-align:top"><p>125</p></td><td style="vertical-align:top"><p>2.18&plusmn;0.99</p></td><td style="vertical-align:top"><p>1.25 (1.0-2.0)</p></td><td style="vertical-align:top"><p>10.16&plusmn;3.04</p></td><td style="vertical-align:top"><p>0.96&plusmn;0.12</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>AMX &ndash; amoxicillin, CA &ndash; clavulanic acid</p><p>*Median (range)</p></td></tr></tbody></table><p>&nbsp;</p><p>Amoxicillin and clavulanic acid serum concentrations achieved with amoxicillin/clavulanic acid are similar to those produced by the oral administration of equivalent doses of amoxicillin or clavulanic acid alone.</p><p>&nbsp;</p><p><u>Distribution </u></p><p>About 25% of total plasma clavulanic acid and 18% of total plasma amoxicillin is bound to protein.</p><p>The apparent volume of distribution is around 0.3-0.4 l/kg for amoxicillin and around 0.2 l/kg for clavulanic acid.</p><p>Following intravenous administration, both amoxicillin and clavulanic acid have been found in gall bladder, abdominal tissue, skin, fat, muscle tissues, synovial and peritoneal fluids, bile and pus.</p><p>Amoxicillin does not adequately distribute into the cerebrospinal fluid.</p><p>From animal studies there is no evidence for significant tissue retention of drug-derived material for either component. Amoxicillin, like most penicillins, can be detected in breast milk. Trace quantities of clavulanic acid can also be detected in breast milk (see section 4.6).</p><p>Both amoxicillin and clavulanic acid have been shown to cross the placental barrier (see section 4.6).</p><p>&nbsp;</p><p><u>Biotransformation</u></p><p>Amoxicillin is partly excreted in the urine as the inactive penicilloic acid in quantities equivalent to up to 10 to 25% of the initial dose. Clavulanic acid is extensively metabolized in man and eliminated in urine and feces and as carbon dioxide in expired air.</p><p>&nbsp;</p><p><u>Elimination </u></p><p>The major route of elimination for amoxicillin is via the kidney, whereas for clavulanic acid it is by both renal and non-renal mechanisms.</p><p>Amoxicillin/clavulanic acid has a mean elimination half-life of approximately one hour and a mean total clearance of approximately 25 l/h in healthy subjects. Approximately 60 to 70% of the amoxicillin and approximately 40 to 65% of the clavulanic acid are excreted unchanged in urine during the first 6 h after administration of single amoxicillin/clavulanic acid 250 mg/125 mg or 500 mg/125 mg tablets. Various studies have found the urinary excretion to be 50-85% for amoxicillin and between 27-60% for clavulanic acid over a 24 hour period. In the case of clavulanic acid, the largest amount of drug is excreted during the first 2 hours after administration.</p><p>Concomitant use of probenecid delays amoxicillin excretion but does not delay renal excretion of clavulanic acid (see section 4.5).</p><p>&nbsp;</p><p><u>Age</u></p><p>The elimination half-life of amoxicillin is similar for children aged around 3 months to 2 years and older children and adults. For very young children (including preterm newborns) in the first week of life the interval of administration should not exceed twice daily administration due to immaturity of the renal pathway of elimination. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p><p>&nbsp;</p><p><u>Gender</u></p><p>Following oral administration of amoxicillin/clavulanic acid to healthy males and female subjects, gender has no significant impact on the pharmacokinetics of either amoxicillin or clavulanic acid.</p><p>&nbsp;</p><p><u>Renal impairment</u></p><p>The total serum clearance of amoxicillin/clavulanic acid decreases proportionately with decreasing renal function. The reduction in drug clearance is more pronounced for amoxicillin than for clavulanic acid, as a higher proportion of amoxicillin is excreted via the renal route. Doses in renal impairment must therefore prevent undue accumulation of amoxicillin while maintaining adequate levels of clavulanic acid (see section 4.2).</p><p>&nbsp;</p><p><u>Hepatic impairment</u></p><p>Hepatically impaired patients should be dosed with caution and hepatic function monitored at regular intervals.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nonclinical data reveal no special hazard for humans based on studies of safety pharmacology, genotoxicity and toxicity to reproduction.</p><p>Repeat dose toxicity studies performed in dogs with amoxicillin/clavulanic acid demonstrate gastric irritancy and vomiting, and discolored tongue.</p><p>Carcinogenicity studies have not been conducted with amoxicillin/clavulanic acid or its components.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>&nbsp;</em></p><ul><li>Microcrystalline cellulose 105,</li><li>sodium starch glycolate,</li><li>colloidal anhydrous silica,</li><li>magnesium stearate,</li><li>polyvinyl alcohol-part.hydrolyzed,</li><li>&nbsp;macrogol 4000,</li><li>talc,</li><li>lecithin</li><li>titanium dioxide (E171).</li></ul><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30<sup>o</sup>C in the original package, in order to protect from light and moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tropicalised blisters, of aluminium-polyvinylchloride-aluminium, with 4, 7, 8 or 10 tablets. Packs of 10, 14, 16, 18 or 20 tablets with patient information leaflet are available. Available also in hospital packs of 100, 500 and 1000 tablets.</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus.

MARKETING AUTHORISATION NUMBER : 
8-718-18

DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION : 

07/10/2014/ 16/04/2018


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>